Complications Based Questions: Difference between revisions
Jump to navigation
Jump to search
Aisha Adigun (talk | contribs) |
Aisha Adigun (talk | contribs) |
||
Line 4: | Line 4: | ||
==Complications Based Questions== | ==Complications Based Questions== | ||
====What population is most at risk for severe disease from COVID-19?==== | ====What population is most at risk for severe disease from COVID-19?==== | ||
*COVID-19 is a new disease and there is limited information regarding risk factors for severe illness. Based on currently available information and clinical expertise, older adults and people of any age who have serious underlying medical conditions might be at higher risk for severe illness from COVID-19. | *COVID-19 is a new disease and there is limited information regarding risk factors for severe illness. Based on currently available information and clinical expertise, older adults and people of any age who have serious underlying medical conditions might be at higher risk for severe illness from COVID-19. | ||
====What risk factors result in severe complications from COVID-19?==== | ====What risk factors result in severe complications from COVID-19?==== | ||
*Information on COVID-19 evolves daily. Current known risk factors include but are not limited to underlying chronic conditions such as; lung disease, moderate to severe asthma, cardiac disease with complications, diabetes, or immunocompromising conditions. | *Information on COVID-19 evolves daily. Current known risk factors include but are not limited to underlying chronic conditions such as; lung disease, moderate to severe asthma, cardiac disease with complications, diabetes, or immunocompromising conditions. | ||
====What systems other than the Respiratory system can be involved?==== | ====What systems other than the Respiratory system can be involved?==== | ||
*Although research for COVID-19 | *Although research for COVID-19 is still ongoing, scientists have found extra-pulmonary manifestations in several other systems. It is thought that the virus instigates a "cytokine storm" where the body responds massively, leading to widespread cytokine release, cellular, tissue, and organ damage. Extra-pulmonary manifestations include but are not limited to; | ||
**Heart Inflammation | **Heart Inflammation | ||
** | **Neurological manifestations | ||
**Renal disease | **Renal disease | ||
**Liver and digestive tract compromise | **Liver and digestive tract compromise | ||
Line 19: | Line 19: | ||
====Does prolonged ventilation in hospitalized patients worsen the outcome of COVID-19?==== | ====Does prolonged ventilation in hospitalized patients worsen the outcome of COVID-19?==== | ||
==Sources== | ==Sources== | ||
<references /> |
Revision as of 21:01, 14 June 2020
Frequently Asked Inpatient Questions Microchapter |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]: Associate Editor(s)-in-Chief:
Complications Based Questions
What population is most at risk for severe disease from COVID-19?
- COVID-19 is a new disease and there is limited information regarding risk factors for severe illness. Based on currently available information and clinical expertise, older adults and people of any age who have serious underlying medical conditions might be at higher risk for severe illness from COVID-19.
What risk factors result in severe complications from COVID-19?
- Information on COVID-19 evolves daily. Current known risk factors include but are not limited to underlying chronic conditions such as; lung disease, moderate to severe asthma, cardiac disease with complications, diabetes, or immunocompromising conditions.
What systems other than the Respiratory system can be involved?
- Although research for COVID-19 is still ongoing, scientists have found extra-pulmonary manifestations in several other systems. It is thought that the virus instigates a "cytokine storm" where the body responds massively, leading to widespread cytokine release, cellular, tissue, and organ damage. Extra-pulmonary manifestations include but are not limited to;
- Heart Inflammation
- Neurological manifestations
- Renal disease
- Liver and digestive tract compromise
- Venous thromboembolism.